AIR-CF1: Adult/Pediatric Clinical Data

Improvements in FEV1 were comparable across adult and pediatric patients on Day 28 of treatment4

CAYSTON AIR-CF1: Adult/Pediatric lung function chart
  • At Day 28, there was a treatment effect of 10.5% (95% CI: 6.4%,14.7%; p<0.0001) in patients ≥18 years
  • At Day 28, there was a treatment effect of 10.4% (95% CI: -1.3%, 22.1%; p=0.0790) in patients <18 years
Learn About Adverse Reactions
NEXT